🇺🇸 FDA
Patent

US 7001600

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

expired A61KA61K2239/31A61K2239/57

Quick answer

US patent 7001600 (Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Secretary, Health and Human Services
Grant date
Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
74
CPC classes
A61K, A61K2239/31, A61K2239/57, A61K39/001156, A61K40/11